ABII » Topics » We are subject to risks associated with international operations, which could harm both our domestic and international operations.

This excerpt taken from the ABII 10-K filed Mar 12, 2010.

We are subject to risks associated with international operations, which could harm both our domestic and international operations.

As part of our business strategy and growth plan, we continue to evaluate international expansion opportunities as we obtain regulatory approvals to market our Abraxane® and other product candidates in foreign countries, including countries in the European Union and Asia. Expansion of our international operations could impose substantial burdens on our resources, divert management’s attention from domestic operations and otherwise harm our business. In addition, international operations are subject to risks, including:

 

   

regulatory requirements of differing nations;

 

   

inadequate protection of intellectual property;

 

   

difficulties and costs associated with complying with a wide variety of complex domestic and foreign laws and treaties;

 

   

legal uncertainties regarding, and timing delays associated with, tariffs, export licenses and other trade barriers; and

 

   

currency fluctuations.

Any of these or other factors could adversely affect our ability to compete in international markets and our operating results.

This excerpt taken from the ABII 10-Q filed May 8, 2009.

We are subject to risks associated with international operations, which could harm both our domestic and international operations.

As part of our business strategy and growth plan, we plan to expand our international sales as we obtain regulatory approvals to market our Abraxane and other product candidates in foreign countries, including countries in the European Union and Asia. Expansion of our international operations could impose substantial burdens on our resources, divert management’s attention from domestic operations and otherwise harm our business. In addition, international operations are subject to risks, including:

 

   

regulatory requirements of differing nations;

 

   

inadequate protection of intellectual property;

 

   

difficulties and costs associated with complying with a wide variety of complex domestic and foreign laws and treaties;

 

   

legal uncertainties regarding, and timing delays associated with, tariffs, export licenses and other trade barriers; and

 

   

currency fluctuations.

Any of these or other factors could adversely affect our ability to compete in international markets and our operating results.

These excerpts taken from the ABII 10-K filed Mar 6, 2009.

We are subject to risks associated with international operations, which could harm both our domestic and international operations.

As part of our business strategy and growth plan, we plan to expand our international sales as we obtain regulatory approvals to market our Abraxane and other product candidates in foreign countries, including countries in the European Union and Asia. Expansion of our international operations could impose substantial burdens on our resources, divert management’s attention from domestic operations and otherwise harm our business. In addition, international operations are subject to risks, including:

 

   

regulatory requirements of differing nations;

 

   

inadequate protection of intellectual property;

 

   

difficulties and costs associated with complying with a wide variety of complex domestic and foreign laws and treaties;

 

   

legal uncertainties regarding, and timing delays associated with, tariffs, export licenses and other trade barriers; and

 

   

currency fluctuations.

Any of these or other factors could adversely affect our ability to compete in international markets and our operating results.

We are subject to risks associated with international operations, which could harm both our domestic
and international operations.

As part of our business strategy and growth plan, we plan to expand our international sales as we obtain
regulatory approvals to market our Abraxane and other product candidates in foreign countries, including countries in the European Union and Asia. Expansion of our international operations could impose substantial burdens on our resources, divert
management’s attention from domestic operations and otherwise harm our business. In addition, international operations are subject to risks, including:

 







  

regulatory requirements of differing nations;

 







  

inadequate protection of intellectual property;

 







  

difficulties and costs associated with complying with a wide variety of complex domestic and foreign laws and treaties;

STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"> 







  

legal uncertainties regarding, and timing delays associated with, tariffs, export licenses and other trade barriers; and

STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"> 







  

currency fluctuations.

Any of these
or other factors could adversely affect our ability to compete in international markets and our operating results.

This excerpt taken from the ABII 10-Q filed Nov 14, 2008.

We are subject to risks associated with international operations, which could harm both our domestic and international operations.

As part of our business strategy and growth plan, we plan to expand our international sales as we obtain regulatory approvals to market our Abraxane and other product candidates in foreign countries, including countries in the European Union and Asia. Expansion of our international operations could impose substantial burdens on our resources, divert management’s attention from domestic operations and otherwise harm our business. In addition, international operations are subject to risks, including:

 

   

regulatory requirements of differing nations;

 

   

inadequate protection of intellectual property;

 

   

difficulties and costs associated with complying with a wide variety of complex domestic and foreign laws and treaties;

 

   

legal uncertainties regarding, and timing delays associated with, tariffs, export licenses and other trade barriers; and

 

   

currency fluctuations.

Any of these or other factors could adversely affect our ability to compete in international markets and our operating results.

This excerpt taken from the ABII 10-Q filed Aug 14, 2008.

We are subject to risks associated with international operations, which could harm both our domestic and international operations.

As part of our business strategy and growth plan, we plan to expand our international sales as we obtain regulatory approvals to market our Abraxane and other product candidates in foreign countries, including countries in the European Union and Asia. Expansion of our international operations could impose substantial burdens on our resources, divert management’s attention from domestic operations and otherwise harm our business. In addition, international operations are subject to risks, including:

 

   

regulatory requirements of differing nations;

 

   

inadequate protection of intellectual property;

 

   

difficulties and costs associated with complying with a wide variety of complex domestic and foreign laws and treaties;

 

   

legal uncertainties regarding, and timing delays associated with, tariffs, export licenses and other trade barriers; and

 

   

currency fluctuations.

Any of these or other factors could adversely affect our ability to compete in international markets and our operating results.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki